Olli Vapalahti

Prof. Olli Vapalahti

Medicum, Department of Virology, University of Helsinki, Helsinki, Finland
orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2020 in Science
Verified
Journal Article
Open access
PDF file
LCLudovico Cantuti-Castelvetri
Ludovico Cantuti-Castelvetri
RORavi Ojha
Ravi Ojha
LPLiliana D. Pedro
Liliana D. Pedro
MDMinou Djannatian
Minou Djannatian
JFJonas Franz
Jonas Franz
MSMikael Simons
Mikael Simons
Another host factor for SARS-CoV-2: Virus-host interactions determine cellular entry and spreading in tissues. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the earlier SARS-CoV use angiotensin-converting enzyme 2 (ACE2) as a receptor; however, their tissue tropism differs, raising the possibility that additional host factors are involved. The spike protein of SARS-CoV-2 contains a cleavage site for the protease furin that is absent from SARS-CoV (see the Perspective by Kielian). Cantuti-Castelvetri et al. now show that neuropilin-1 (NRP1), which is known to bind furin-cleaved substrates, potentiates SARS-CoV-2 infectivity. NRP1 is abundantly expressed in the respiratory and olfactory epithelium, with highest expression in endothelial and epithelial cells. Daly et al. found that the furin-cleaved S1 fragment of the spike protein binds directly to cell surface NRP1 and blocking this interaction with a small-molecule inhibitor or monoclonal antibodies reduced viral infection in cell culture. Understanding the role of NRP1 in SARS-CoV-2 infection may suggest potential targets for future antiviral therapeutics. Science , this issue p. 856 , p. 861 ; see also p. 765

1 April 2010 in Clinical Microbiology Reviews
Verified
Journal Article
Closed access
CJColleen Jonsson
Colleen Jonsson
LFLuiz Tadeu Moraes Figueiredo
Luiz Tadeu Moraes Figueiredo
OVOlli Vapalahti
Olli Vapalahti
SUMMARY: Hantaviruses are enzootic viruses that maintain persistent infections in their rodent hosts without apparent disease symptoms. The spillover of these viruses to humans can lead to one of two serious illnesses, hantavirus pulmonary syndrome and hemorrhagic fever with renal syndrome. In recent years, there has been an improved understanding of the epidemiology, pathogenesis, and natural history of these viruses following an increase in the number of outbreaks in the Americas. In this review, current concepts regarding the ecology of and disease associated with these serious human pathogens are presented. Priorities for future research suggest an integration of the ecology and evolution of these and other host-virus ecosystems through modeling and hypothesis-driven research with the risk of emergence, host switching/spillover, and disease transmission to humans.

2 June 2016 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
RDRita W. Driggers
Rita W. Driggers
CHCheng-Ying Ho
Cheng-Ying Ho
EKEssi Korhonen
Essi Korhonen
SKSuvi Kuivanen
Suvi Kuivanen
AJAnne J. Jääskeläinen
Anne J. Jääskeläinen
OVOlli Vapalahti
Olli Vapalahti
The current outbreak of Zika virus (ZIKV) infection has been associated with an apparent increased risk of congenital microcephaly. We describe a case of a pregnant woman and her fetus infected with ZIKV during the 11th gestational week. The fetal head circumference decreased from the 47th percentile to the 24th percentile between 16 and 20 weeks of gestation. ZIKV RNA was identified in maternal serum at 16 and 21 weeks of gestation. At 19 and 20 weeks of gestation, substantial brain abnormalities were detected on ultrasonography and magnetic resonance imaging (MRI) without the presence of microcephaly or intracranial calcifications. On postmortem analysis of the fetal brain, diffuse cerebral cortical thinning, high ZIKV RNA loads, and viral particles were detected, and ZIKV was subsequently isolated.

1 May 2008 in The Lancet
Verified
Journal Article
Closed access
LLLars Lindquist
Lars Lindquist
OVOlli Vapalahti
Olli Vapalahti

1 October 2003 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
OVOlli Vapalahti
Olli Vapalahti
JMJukka Mustonen
Jukka Mustonen
ÅLÅke Lundkvist
Åke Lundkvist
HHHeikki Henttonen
Heikki Henttonen
APAlexander Plyusnin
Alexander Plyusnin
AVAntti Vaheri
Antti Vaheri

1 November 1996 in Journal of General Virology
Verified
Journal Article
Closed access
APAlexander Plyusnin
Alexander Plyusnin
OVOlli Vapalahti
Olli Vapalahti
AVAntti Vaheri
Antti Vaheri
Introduction. The isolation by Ho Wang Lee and collaborators of the virus causing Korean haemorrhagic fever, now called Hantaan virus (HTN), from the lungs of striped field mice (Apodemus agrarius) in 1976 (Lee & Lee, 1976) launched a new era in the study of haemorrhagic fever with renal syndrome (HFRS) throughout the world. This was soon followed by the discovery of the causative agent of the European form of HFRS, nephropathia epidemica, now known as Puumala virus (PUU) (Brummer-Korvenkontio et al., 1980), and of the urban rat virus, Seoul virus (SEO) (Lee et al., 1980). The identification in 1993 of Sin Nombre virus (SN) as the causative agent of hantavirus-associated pulmonary syndrome (HPS) (Nichol et al., 1993a) led to intensive search for further hantaviruses and as a result today a total of as many as 16 well-established sero/genotypes may be listed.